Barrett & Company’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.4K Buy
477
+14
+3% +$1.12K 0.01% 342
2026
Q1
$38.8K Hold
463
0.01% 319
2025
Q4
$31K Hold
463
0.01% 347
2025
Q3
$31.3K Hold
463
0.01% 349
2025
Q2
$34.5K Sell
463
-404
-47% -$26.9K 0.01% 349
2025
Q1
$54.6K Sell
867
-56
-6% -$3.46K 0.02% 257
2024
Q4
$52.6K Buy
923
+72
+8% +$4.26K 0.02% 263
2024
Q3
$50K Sell
851
-70
-8% -$3.82K 0.02% 264
2024
Q2
$49.7K Buy
921
+1
+0.1% +$55 0.02% 263
2024
Q1
$53K Buy
920
+437
+90% +$22.6K 0.03% 266
2023
Q4
$23.1K Buy
483
+2
+0.4% +$95 0.01% 334
2023
Q3
$24.6K Buy
481
+1
+0.2% +$53 0.01% 317
2023
Q2
$27.5K Buy
480
+1
+0.2% +$58 0.02% 310
2023
Q1
$28.9K Buy
479
+1
+0.2% +$61 0.02% 284
2022
Q4
$28.1K Hold
478
0.02% 278
2022
Q3
$28.1K Buy
+478
New +$27.9K 0.02% 278

Other funds holding CTVA

Barrett & Company's CTVA Position: Q2 2026 in Review

Barrett & Company increased its Corteva (CTVA) stake by 3% in Q2 2026, buying an estimated $1.12K and bringing the position to 477 shares worth $40.4K. The position accounts for 0.01% of the portfolio, ranked #342.

Barrett & Company first reported a position in CTVA in Q3 2022 and has held it in 16 quarters since. The position peaked at $54.6K in Q1 2025. 1,494 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Barrett & Company held 477 shares of Corteva worth $40.4K as of Q2 2026.
  • Barrett & Company bought 14 Corteva shares in Q2 2026, an estimated $1.12K.
  • Corteva made up 0.01% of Barrett & Company's portfolio in Q2 2026, its #342 holding.
  • Barrett & Company first reported a position in Corteva in Q3 2022 and has held it in 16 quarters since.
  • Barrett & Company's Corteva position peaked at $54.6K in Q1 2025.
  • 1,494 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.